The world’s largest chemical company is advancing its historic corporate overhaul at a faster pace than initially projected. While a substantial share buyback initiative and surpassed cost-saving targets aim to bolster investor sentiment, geopolitical challenges and persistent weakness in its core European market are tempering expectations for the current fiscal year.
Tangible results are emerging from management’s stringent cost discipline. By the end of 2025, BASF had increased its annualized savings to €1.7 billion, exceeding its own targets. The goal for the ongoing year has now been raised to €2.3 billion. Concurrently, the company is actively supporting its share price, acquiring 3.6 million of its own shares in the first week of March alone. Since the start of the year, the stock has posted a solid gain of approximately 7.5%, reflecting market participants’ confidence in the swift execution of these operational measures.
Portfolio Reshaping and a Cautious Financial Horizon
To accelerate its focus on more profitable core segments, BASF is currently streamlining its portfolio on multiple fronts. Recent transactions highlight the strategic direction:
- The sale of its optical brighteners business (completed in late February 2026)
- The planned divestment of its coatings division in the second quarter of 2026
- The acquisition of Texas-based biopesticide specialist AgBiTech
The U.S. acquisition, in particular, paves the way for a larger strategic move. The agricultural business is being deliberately strengthened with the intention of spinning off a portion via an initial public offering in 2027.
Should investors sell immediately? Or is it worth buying BASF?
The broader market environment, however, remains difficult. For 2026, BASF leadership anticipates operating earnings (EBITDA) in a range of €6.2 billion to €7.0 billion. The midpoint of this guidance falls notably short of the previous consensus estimates from analysts. Elevated U.S. tariffs, a weaker U.S. dollar, and continued subdued demand within the European Union are all weighing on performance.
This operational caution is mirrored in the company’s cash flow outlook. The projected free cash flow of up to €2.3 billion is expected to be insufficient to fully cover the planned dividend of €2.25 per share from ongoing earnings. Nevertheless, the group remains committed to the payout to retain investors during this transitional phase.
The full impact of the first-quarter restructuring will be revealed in the upcoming official figures. BASF is scheduled to present its latest quarterly results on April 30, 2026, and will face shareholders at its Annual Meeting in Mannheim on the same day. Until a broader market recovery—which CEO Markus Kamieth does not foresee before 2027—the multi-billion-euro shareholder returns serve as a financial bridge for investors.
Ad
BASF Stock: Buy or Sell?! New BASF Analysis from March 16 delivers the answer:
The latest BASF figures speak for themselves: Urgent action needed for BASF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 16.
BASF: Buy or sell? Read more here...









